Funder: American Association for Cancer Research
Due Dates (Anticipated): May 2026 (Letter of Intent) | June 2026 (Full Application) | September 2026 (Full Application, projected)
Funding Amounts: $300,000 total over 3 years; supports PI salary, personnel, supplies, equipment, limited travel, and indirect costs (max 10%).
Summary: Supports early-career researchers advancing innovative cancer research using Tumor Treating Fields, with required use of the Inovitro® system.
Key Information: All dates are projected based on the annual cycle; check the program page for updates.